ECP 2022 Final Programme

Tuesday, 6 Sept 173 ECP 2022 Basel 003 13:23–13:58 The changing landscape of healthcare policies in the era of personalized oncology Rolf Stahel, Switzerland 004 13:58–14:18 Nurses, key partners in the transition to personalized medicine in oncology – Panel discussion Jackie Fenemore, United Kingdom Rolf Stahel, Switzerland Paul Hofman, France 005 14:18–14:30 Q&A with the audience and Meeting closure Paul Hofman, France LS-17 Industry Symposium 13:00–14:30 Delhi Rapid Precision Diagnostics Sharpening Treatment Decisions in NSCLC (Biocartis) Chair: Alison Finall, United Kingdom 001 Targeted therapy based on genomic analysis in NSCLC Garcia-Foncillas Jesus, Spain 002 Integration of rapid PCR testing as an adjunct to NGS in diagnostic pathology services within the UK: Evidence from a case series of non-squamous, NS Alison Finall, United Kingdom 003 Multicenter NSCLC comparison study using Idylla™ GeneFusion Arndt Hartmann, Germany 004 Q&A moderated by Chair: Alison Finall ES-04 Industry Symposium 19:45–20:45 Osaka/Samarkand AI-powered digital pathology platform: intro and practical use cases from translational research to diagnostics (Aifora Technologies) Chair: Thomas Westerling-Bui, Finland 001 Welcome and introduction Thomas Westerling-Bui, Finland 002 Live demonstration of Aiforia’s cloud-based platform and how deep learning AI can bring precision to tasks like tumor grading, PD-L1 scoring Thomas Westerling-Bui, Finland 003 Using the robust Aiforia platform to help predict ovarian tumor outcome, specifically in high-grade extrauterine serous carcinoma Anna Laury, Finland 004 Q&A Thomas Westerling-Bui, Finland Industry Symposia